Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ligand-mediated decrease of thyroid hormone receptor-alpha1 in cardiomyocytes by proteosome-dependent degradation and

Agnes Kenessey1, Kaie Ojamaa

  • 1North Shore-Long Island Jewish Research Institute, Manhasset, New York 11030, USA. kojamaa@nshs.edu

American Journal of Physiology. Heart and Circulatory Physiology
|October 23, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Super-Resolution 3D Imaging Reveals Disarray of Dyadic Calcium Ion Channels in Failing Hearts Expressing Low Thyroid Hormone Function.

International journal of molecular sciences·2026
Same author

Rethinking strategies for solving thyroid dysfunction at the heart of cardiovascular disease.

Molecular medicine (Cambridge, Mass.)·2025
Same author

Failing hearts are more vulnerable to dobutamine and caffeine-induced ventricular arrhythmias: Ameliorated with dantrolene treatment.

Heart rhythm O2·2025
Same author

Nanoscale organization of cardiac calcium channels is dependent on thyroid hormone status.

American journal of physiology. Heart and circulatory physiology·2024
Same author

Alcohol and caffeine synergistically induce spontaneous ventricular tachyarrhythmias: ameliorated with dantrolene treatment.

Heart rhythm O2·2023
Same author

Stabilizing Cardiac Ryanodine Receptor With Dantrolene Treatment Prevents Binge Alcohol-Enhanced Atrial Fibrillation in Rats.

Journal of cardiovascular pharmacology·2022

Tri-iodothyronine (T3) reduces cardiac TRalpha1 protein by increasing proteasome degradation and decreasing mRNA stability. This T3 action on thyroid hormone receptors (TRs) is crucial for cardiac function and offers therapeutic targets.

Area of Science:

  • Cardiology
  • Molecular Endocrinology
  • Cell Biology

Background:

  • Tri-iodothyronine (T3) is vital for normal cardiac contractile function.
  • T3 effectiveness depends on hormone availability and nuclear thyroid hormone receptor (TR) isoforms (TRalpha1, TRbeta1).

Purpose of the Study:

  • To investigate the mechanisms by which T3 reduces nuclear TRalpha1 protein in cardiomyocytes.
  • To explore the roles of proteasome degradation and mRNA stability in T3-mediated TRalpha1 regulation.

Main Methods:

  • Cultured neonatal rat ventricular myocytes were treated with T3.
  • Overexpression of TRalpha1 using adenoviruses.
  • Proteasome pathway inhibition.
  • Quantitative RT-PCR and mRNA half-life measurements.

Related Experiment Videos

  • Reporter plasmid transfection to assess transcriptional activity.

    • Main Results:

    • T3 treatment significantly decreased TRalpha1 protein and mRNA levels within 4 hours.
    • Proteasome inhibitors prevented T3-induced degradation of ubiquitylated TRalpha1.
    • T3 significantly reduced TRalpha1 mRNA half-life but not TRbeta1 mRNA half-life.
    • TRalpha1 transcriptional activity was inversely proportional to nuclear TRalpha1 content.

    Conclusions:

    • T3 induces a decrease in nuclear TRalpha1 in cardiomyocytes via proteasome-mediated degradation and altered mRNA stability.
    • These findings identify novel cellular targets for therapeutic development in cardiac T3 regulation.